Table 1.
Summary of the data available in the ESurv.
| Cancers with available omics data | Messenger RNA (Yes/No) | MicroRNA (Yes/No) | Methylation (Yes/No) | Total patients, n |
| Acute myeloid leukemia | Yes | Yes | Yes | 200 |
| Adrenocortical carcinoma | Yes | Yes | Yes | 92 |
| Bladder urothelial carcinoma | Yes | Yes | Yes | 412 |
| Brain lower grade glioma | Yes | Yes | Yes | 515 |
| Breast invasive carcinoma | Yes | Yes | Yes | 1097 |
| Cervical and endocervical carcinoma | Yes | Yes | Yes | 307 |
| Cholangiocarcinoma | Yes | Yes | Yes | 45 |
| Colon adenocarcinoma | Yes | Yes | Yes | 458 |
| Esophageal carcinoma | Yes | Yes | Yes | 185 |
| Glioblastoma multiforme | Yes | No | Yes | 595 |
| Head and neck squamous cell carcinoma | Yes | Yes | Yes | 528 |
| Kidney chromophobe | Yes | Yes | Yes | 113 |
| Kidney renal clear cell carcinoma | Yes | Yes | Yes | 537 |
| Kidney renal papillary cell carcinoma | Yes | Yes | Yes | 291 |
| Liver hepatocellular carcinoma | Yes | Yes | Yes | 377 |
| Lung adenocarcinoma | Yes | Yes | Yes | 522 |
| Lung squamous cell carcinoma | Yes | Yes | Yes | 504 |
| Lymphoid neoplasm diffuse large B cell lymphoma | Yes | Yes | Yes | 48 |
| Mesothelioma | Yes | Yes | Yes | 87 |
| Ovarian serous cystadenocarcinoma | Yes | Yes | No | 591 |
| Pancreatic adenocarcinoma | Yes | Yes | Yes | 185 |
| Pheochromocytoma and paraganglioma | Yes | Yes | Yes | 179 |
| Prostate adenocarcinoma | Yes | Yes | Yes | 499 |
| Rectum adenocarcinoma | Yes | Yes | Yes | 171 |
| Sarcoma | Yes | Yes | Yes | 261 |
| Skin cutaneous melanoma | Yes | Yes | Yes | 470 |
| Stomach adenocarcinoma | Yes | Yes | Yes | 443 |
| Testicular germ cell tumor | Yes | Yes | Yes | 134 |
| Thymoma | Yes | Yes | Yes | 124 |
| Thyroid carcinoma | Yes | Yes | Yes | 516 |
| Uterine carcinosarcoma | Yes | Yes | Yes | 57 |
| Uterine corpus endometrial carcinoma | Yes | Yes | Yes | 548 |
| Uveal melanoma | Yes | Yes | No | 80 |